UNIDO and EU support Georgian pharmaceutical cluster
UNIDO, with the financial support of the European Union (EU), organized an interactive two-day training programme on 30-31 May 2022 focusing on the Good Manufacturing Practice (GMP) for the Georgian Pharmaceutical Cluster. The training prompted great interest amongst the beneficiaries and UNIDO will continue working with cluster members for an easier uptake of GMP.
The Georgian Pharmaceutical Cluster, which unites the manufacturers of bacteriophages and herbal pharmaceuticals as well as support institutions, aims to capitalize on the existing opportunities to enhance the competitiveness of member producers, increase sales and access new markets by introducing GMP quality standards and schemes.
Even though GMP presents the major opportunity for the producers to access international and the EU markets, the majority of cluster members are still in the process of adjusting their processes and facilities to meet GMP requirements as it entails significant financial investments and human resources. GMP became a mandatory standard in Georgia starting in 2022, however, some exceptions for the adoption of the standard were granted to the sector.
The training was organized as part of the UNIDO project “EU Innovative Action for Private Sector Competiveness in Georgia”, which is implemented jointly with the UN agencies of the United Nations Development Programme (UNDP), Food and Agriculture Organization (FAO), and International Organization for Migration (IOM).
For further information contact Fabio Russo (F.Russo [at] unido.org (F).Russo [at] unido.org)